3D inpatient dose reconstruction from the PET-CT imaging of 90 Y microspheres for metastatic cancer to the liver: Feasibility study

2013 ◽  
Vol 40 (8) ◽  
pp. 081702 ◽  
Author(s):  
E. Fourkal ◽  
I. Veltchev ◽  
M. Lin ◽  
S. Koren ◽  
J. Meyer ◽  
...  
Keyword(s):  
Feasibility Study ◽  
Metastatic Cancer ◽  
Ct Imaging ◽  
Dose Reconstruction ◽  
Pet Ct

WE-A-BRB-06: 3D In-Patient Dose Reconstruction from the PET-CT Imaging of Y-90 Microspheres for Metastatic Cancer to the Liver

2012 ◽  
Vol 39 (6Part25) ◽  
pp. 3932-3932 ◽  
Author(s):  
E Fourkal ◽  
I Veltchev ◽  
S Koren ◽  
M Lin ◽  
C Ma ◽  
...  
Keyword(s):  
Metastatic Cancer ◽  
Ct Imaging ◽  
Patient Dose ◽  
Dose Reconstruction ◽  
Pet Ct

scholarly journals Non-small-cell Lung Cancer Metastases to Diaphragm and Spleen Visualized on F-18 FDG-PET/CT Imaging: A Case Report

2020 ◽  
Vol 1 (3) ◽  
Author(s):  
Anindita Rani Paul ◽  
Rajib Paul Chowdhury ◽  
Pritam Saha Podder ◽  
Umme Saoda
Keyword(s):  
Lung Cancer ◽  
Cancer Patient ◽  
Lung Cancer Patient ◽  
Malignant Tumors ◽  
Imaging Modality ◽  
Tumor Staging ◽  
Metastatic Cancer ◽  
Primary Lung Cancer ◽  
Ct Imaging ◽  
Pet Ct

The leading cause of cancer-related death worldwide is lung cancer. While hematogenous spread from primary lung cancer to multiple other organs is frequently reported, metastases of malignant tumors to diaphragm and to spleen are rare. Nowadays, Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) has evolved in such a way that it has become a useful imaging modality in the assessment of various cancers, particularly for tumor staging and post treatment monitoring. It is able to provide metabolic information. In this case, we present an interesting integrated PET/CT imaging in a lung cancer patient with rare, diaphragm and splenic metastases. So, PET/CT could very well demonstrated rare and unexpected metastatic cancer and provided more accurate staging in a lung cancer patient.

SU-FF-J-44: PET/CT Imaging for 3D In-Vivo Treatment Verification in ProtonTherapy - a Feasibility Study

2005 ◽  
Vol 32 (6Part4) ◽  
pp. 1929-1929
Author(s):  
K Parodi ◽  
T Bortfeld ◽  
H Paganetti ◽  
E Cascio ◽  
J Flanz ◽  
...  
Keyword(s):  
Feasibility Study ◽  
Ct Imaging ◽  
Treatment Verification ◽  
Pet Ct ◽  
In Vivo Treatment

SU-E-T-189: First Experimental Verification of the Accuracy of Absolute Dose Reconstruction From PET-CT Imaging of Yttrium 90 Microspheres

2014 ◽  
Vol 41 (6Part14) ◽  
pp. 266-266
Author(s):  
I Veltchev ◽  
E Fourkal ◽  
M Doss ◽  
C Ma ◽  
J Meyer ◽  
...  
Keyword(s):  
Experimental Verification ◽  
Ct Imaging ◽  
Dose Reconstruction ◽  
Pet Ct ◽  
Yttrium 90

The rise and fall of PET and PET/CT

2005 ◽  
Vol 44 (S 01) ◽  
pp. S58-S60 ◽  
Author(s):  
W. Mohnike
Keyword(s):  
Clinical Practice ◽  
General Hospital ◽  
Private Practice ◽  
Ct Imaging ◽  
Hospital Environment ◽  
Governmental Organizations ◽  
Pet Ct

Summary:PET is being considered a diagnostic commodity in clinical practice worldwide and thus receives increasing attention by health insurances and governmental organizations. In Germany, however, neither PET nor PET/CT are subject to reimbursement. This renders clinical PET and PET/CT imaging a challenge both in a general hospital environment and in private practice. This article describes briefly these challenges, which are not solely related to turf battles and associated costs.

Sign in / Sign up

Export Citation Format

Share Document